[1]
|
[1] N. Hen, M. Bialer, B. Wlodarczyk, R. H. Finnell and B. Yagen, “Syntheses and Evaluation of Anticonvulsant Pro-file and Teratogenicity of Novel Amide Derivatives of Branched Aliphatic Carboxylic Acids with 4-Aminobenz- ene sulfonamide,” Journal Medical Chemistry, Vol. 53, No. 10, 2010, pp. 4177-4186. doi:10.1021/jm100170w
|
[2]
|
[2] F.Carta, A. Maresca, A. Scozzafava, D. Vullo and C. T. Supuran, “Carbonic Anhydrase Inhibitors. Diazenylben-zenesulfonamides are Potent and Selective Inhibitors of the Tumor-Associated Isozymes IX and XII over the Cytosolic Isoforms I and II,” Bioorganic & Medical Chemistry, 2009, Vol. 17, No.20, 7093-7099. doi:10.1016/j.bmc.2009.09.003
|
[3]
|
[3] K. Namba, X. Zheng, K. Motoshima, H. Kobayashi, A. Tai, E. Takahashi, K. Sasaki, K. Okamoto and H. Kakuta, “De-sign and Synthesis of Benzenesulfonanilides Active against Methicillin-Resistant Staphylococcus Aureus and Vanco-mycin-Resistant,” Enterococcus Bioorganic & Medical Chemistry, Vol. 16, No. 11, 2008, pp. 6131-6144.
|
[4]
|
[4] P. Joseph, F. Turtaut, S. Ouahrani-Bettache, J. L. Montero, I. Nishimori, T. Minakuchi, D. Vullo, A. Scozzafava, S. Kohler, J.-Y. Winum and C. T. Supuran. “Cloning, Char-acterization, and Inhibition Studies of a β-Carbonic Anhy-drase from Brucella suis,” Journal Medical Chemistry, 2010, Vol. 53, No. 5, pp 2277-2285.
doi:10.1021/jm901855h
|
[5]
|
[5] B. L. Wilkinson, L. F. Bornaghi, A. D. Wright, T. A. Houston and S. A. Poulsen, “Anti-Mycobacterial Activity of a Bis-Sulfonamide,” Bioorganic & Medical Chemistry Letter, Vol. 17, No. 5, 2007, pp. 1355-1357.
doi:10.1016/j.bmcl.2006.11.079
|
[6]
|
[6] B. G. Katzung, Basic and Clinical Pharma cology, 6th ed.; University of California: San Francisco, 1995.
|
[7]
|
[7] S. Joshi and N. Khosla, “QSAR Study on Anti Bacterial Activity of Sulfonamides and Derived Mannich Bases,” Bioorganic Medical Chemistry Letter, Vol. 13, No. 21, 2003, pp. 3747-3751. doi:10.1016/j.bmcl.2003.08.017
|
[8]
|
[8] S. Joshi, N. Khosla and P. Tiwari, “In Vitro Study of Some Medicinally Important Mannich Bases Derived from an An-titubercular Agent,” Bioorganic & Medical Chemistry, Vol. 12, No. 3, 2004, pp. 571-576.
doi:10.1016/j.bmc.2003.11.001
|
[9]
|
[9] N. Anand, “Sulfonamides and Sulfones. In Burger’s Me-dicinal Chemistry and Drug Discovery,” New York, 1996, pp. 527-573.
|
[10]
|
[10] A. Kamal, M. N. A. Khan, K. S. Reddy, K. Rohini, G. N.
Sastry, B. Sateesh and B. Sridhar, “Synthesis, Structure Analysis and Antibacterial Activity of Some Novel 10-Substituted 2-(4-Piperidyl/Phenyl) -5, 5-Dioxo [1,2,4] triazolo [1,5b] [1,2,4] Benzothiadiazine Derivatives,” Bio-organic & Medical Chemistry Letter, Vol. 17, 2007, pp. 5400-5405. doi:10.1016/j.bmcl.2007.07.043
|
[11]
|
[11] S. Zimmerman, A. Innocenti, A. Casini, J. G. Ferry, A. Scozzafava and C. T. Supuran, “Carbonic Anhydrase In-hibitors. Inhibition of the Prokaryotic Beta and Gamma- Class Enzymes from Archaea with Sulfonamides,” Bioor-ganic & Medical Chemistry Letter, Vol. 14, 2004, pp. 6001-6006. doi:10.1016/j.bmcl.2004.09.085
|
[12]
|
[12] V. Garaj, L. Puccetti, G. Fasolis, J-Y. Winum, J-L. Mon-tero, A. Scozzafava, D. Vullo, A. Innocentia and C. T. Su-purana, “Carbonic Anhydrase Inhibitors: Synthesis and In-hibition of Cytosolic/Tumor-Associated Carbonic Anhy-drase Isozymes I, Ii, and Ix with Sulfonamides Incorporat-ing 1,2,4-Triazine Moieties,” Bioorganic Medical Chemis-try Letter, Vol. 14, 2004, pp. 5427-5433.
doi:10.1016/j.bmcl.2004.07.087
|
[13]
|
[13] L. Puccetti, G. Fasolis, D. Vullo, Z. H. Chohan, A. Scoz-zafavab and C. T. Supuranb, “Carbonic Anhydrase Inhibitors. Inhibition of Cytosolic/Tumor-Associated Carbonic Anhy-drase Isozymes I, II, IX, and XII with Schiff Bases Incorpo-rating Chromone and Aromatic Sulfonamide Moieties, and Their Zinc Complexes,” Bioorganic & Medical Chemistry Letter, Vol. 15, 2005, pp.
3096-3101.doi:10.1016/j.bmcl.2005.04.055
|
[14]
|
[14] J. M. Lehtonen, S. Parkkila, D. Vullo, A. Casini, A. Scoz-zafavac and C. T. Supuranc, “Carbonic Anhydrase Inhibi-tors. Inhibition of Cytosolic Isozyme XIII with Aromatic and Heterocyclic Sulfonamides: A Novel Target for the Drug Design,” Bioorganic& Medical Chemistry Letter, Vol. 14, 2004, pp. 3757-3762. doi:10.1016/j.bmcl.2004.04.106
|
[15]
|
[15] O. Güzel, A. Innocenti, A. Scozzafava, A. Salman and C. T. Supuran, “Carbonic Anhydrase Inhibitors. Phenacetyl-, Pyridylacetyl- and Thienylacetyl-Substituted Aromatic Sulfonamides Act as Potent and Selective Isoform Vii In-hibitors,” Bioorganic & Medical Chemistry Letter, Vol. 19, 2009, pp. 3170-3173. doi:10.1016/j.bmcl.2009.04.123
|
[16]
|
[16] A. Scozzafava, T. Owa, A. Mastrolorenzo and C. T. Supu-ran, “Anticancer and Antiviral Sulfonamides,” Current Medical Chemistry Vol. 10 No. 11, 2003, pp. 925-953.
doi:10.2174/0929867033457647
|
[17]
|
[17] A. Weber, A. Casini, A. Heine, D. Kuhn, C. T. Supuran, A. Scozzafava and G. Kiebe, G. “Unexpected Nanomolar In-hibition of Carbonic Anhydrase by COX-2-Selective Cele-coxib: New Pharmacological Opportunities Due to Related Binding Site Recognition,” Journal Medical Chemistry, Vol. 47, No.3, 2004, pp. 550-557. doi:10.1021/jm030912m
|
[18]
|
[18] G. M. Brown, “Biosynthesis of Folic Acid. II. Inhibition by Sulfonamides,” Journal Biological Chemistry, Vol. 237, No. 1962, pp. 536-540.
|
[19]
|
[19] P. Huovinen, L. Sundstr?m, G. Swedberg, O. Skold and Antimicrob, “Agents Chemother Trimethoprim and Sul-fonamide Resistance,” Antimicrobiology.Agents and Che-motherapy, Vol. 39, No.2, 1995, pp. 279-289.
|